Inventor · disambiguated record
David Lebwohl
Also filed as: LEBWOHL DAVID · LEBWOHL DAVID E
5 granted patents·5 pending applications·33 citations·filing 2001–2022
79Inventor score
Files withNOVARTIS AG4BRISTOL MYERS SQUIBB CO2MARKS PETER WAYNE2BERG WILLIAM1INTELLIA THERAPEUTICS INC1
Top patents by PatentIndex Score
10 records- 0187US11344620B2Combination therapiesNOVARTIS AG·Filed 2015·Granted May 31, 2022·5 cites·36 claims
- 0287US9993551B2Combination therapies of EGFR inhibitorsNOVARTIS AG·Filed 2015·Granted Jun 12, 2018·8 cites·14 claims
- 0374US7008936B2Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Mar 7, 2006·12 cites·8 claims
- 0472US9006224B2Neuroendocrine tumor treatmentMARKS PETER WAYNE·Filed 2006·Granted Apr 14, 2015·6 cites·3 claims
- 0572US2024075136A1Combination therapiesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0668US6573285B2Method for preventing or treating pain by administering an endothelin antagonistBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jun 3, 2003·2 cites·3 claims
- 0756US2025269062A1Methods for in vivo editing of a liver geneINTELLIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0843US2010305150A1Tuberous sclerosis treatmentBERG WILLIAM·Filed 2007·Application pending·0 cites
- 0943US2017128425A1Neuroendocrine Tumor TreatmentNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1033US2015148294A1Neuroendocrine Tumor TreatmentMARKS PETER WAYNE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Lebwohl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →